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Background: Rheumatic valve disease is an important public health problem in developing
countries. We sought to evaluate the possible role of blood antigens as a risk factor for
severe rheumatic valve disease.
Methods: Two hundred and ﬁfty-four patients with severe rheumatic mitral and/or aortic
valve disease with the surgical indication were enrolled to the study. Control group was
composed of age and gender matched 2668 healthy volunteers.
Results: There were 216 patients with aortic valve involvement and 249 patients with
mitral valve involvement. One hundred and seventy-ﬁve patients had mitral stenosis, 96
patients had severe mitral regurgitation and 61 patients had severe aortic regurgitation.
The distribution of blood groups among patients was as follows: Group A¼42.9%, Group
B¼19.2%, Group AB¼8.6%, and Group O¼29.1%. The distribution of blood groups in the
control group was Group A¼40.8%, Group B¼16.4%, Group AB¼7.6%, and Group O¼35.1%.
There was no signiﬁcant difference between blood groups of patients and controls (p¼0.141).
Conclusion: Blood group does not seem to be a risk factor for rheumatic valve involvement or
severity of the disease.
& 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
.1. Introduction
Rheumatic valve disease is an important public health pro-
blem in developing countries [1]. It is an important sequelae
of the acute rheumatic fever which is an immune mediated
response to pharyngeal infections caused by β-hemolyticch Society of Cardiology.
, +90 342 3676286; fax:+9
(S. Ercan).Streptococcus. Active inﬂammation and carditis frequently
progress to stenosis and/or regurgitation of the affected valve
[2]. Factors associated with disease progression are not
clearly understood.
ABO antigens, also known as blood group antigens, are
ubiquitously found in the body and are important players ofPublished by Elsevier Urban & Partner Sp.z o.o. All rights reserved.
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risk factor for certain infectious diseases, chronic inﬂamma-
tory diseases, cancers and cardiovascular diseases [3]. We
sought to determine the association between blood group
antigens and rheumatic heart disease. Blood groups of
patients with severe rheumatic valve disease living in South-
eastern Anatolian Region, where rheumatic heart disease is
endemic [1], were compared with the blood groups of healthy
volunteers living in the same region.2. Method
In our clinic, 254 patients with severe rheumatic mitral and/
or aortic valve disease with surgical indication for correction
were enrolled to the study. Blood groups of the patients were
determined using standard haemagglutination tests. Control
group consisted of 2668 healthy volunteers who donated
blood to the Turkish Red Crescent in Gaziantep region. Data
were analyzed using Statistical Package for Social Sciences
(SPSS) version 16.0. Categorical variables were expressed as
counts or percentages, and compared using a χ2 test. In all
two sided analyses a p-valueo0.05 was considered to be
statistically signiﬁcant. For sample size power we estimated
that we need to study at least 245 patients to be able to reject
the null hypothesis that the exposure rates for case and
controls are equal with probability (power) 0.8. The probabil-
ity of Type I error associated with the null hypothesis of this
test is 0.05.3. Results
Mean age was 39 years (16–74) and female/male ratio was 89/
165. There were 216 patients with aortic valve involvement
and 249 patients with mitral valve involvement. One hundred
and seventy-ﬁve patients had mitral stenosis, 96 patients had
severe mitral regurgitation and 61 patients had severe aortic
regurgitation. The blood groups of the patients were as
follows: Group A 42.9% (n¼109), Group B 19.2% (n¼49), Group
AB 8.6% (n¼22), and Group O 29.1% (n¼74). Blood groups of
the control group were Group A: 40.8% (n¼1090), Group B:
16.4% (n¼439), Group AB: 7.6% (n¼204), and Group O: 35.1%
(n¼935). There was no signiﬁcant difference between blood
groups of patients and controls (p¼0.141). In addition, there
was not any signiﬁcant association between blood groups
and mitral valve area (p¼0.294), severity of mitral and aortic
regurgitation (p¼0.581 and p¼0.542 respectively).4. Discussion
In our study, we compared population based blood group
antigens with blood groups of patients known to have severe
rheumatic valve disease and sought to determine whether
blood group per se is associated with the severity of the
valvular disease.
Etiopathogenesis of rheumatic valve disease, although one
of the oldest heart diseases, is still not clearly understood. In
addition, why some patients recover completely and somepatients experience a progressive disease is still an unresolved
problem. Environmental and genetic factors are put forward but
none have been consistently shown to be the cause.
Western countries researched the possible association
between blood group antigens and rheumatic heart disease
in relatively older times when rheumatic disease was fre-
quent. [4,5]. In 1960s, echocardiography was not available and
rheumatic heart disease was diagnosed by physical examina-
tion alone and results were conﬂicting.
Along with covering the surface of red blood cells, blood
group antigens are found ubiquitously in the body, especially
the parts which are in contact with the outside such as
respiratory tract and gastrointestinal system. These antigens
also have an important role in the elimination process of
infectious agents [2]. Studies suggest that inﬂammatory
response to certain infectious agents may vary according to
the blood group antigens [6]. Clarke et al. [4] reported that
patients with blood group O have a decreased tendency
towards Streptococcus infections and also have a lower risk
for rheumatic mitral stenosis and poststrepotoccocic glomer-
ulonephritis. However there are some reports indicating the
absence of such relationship [5]. We evaluated the associa-
tion between the blood group antigens and severe rheumatic
valve disease but could not ﬁnd any relationship compared to
control group. Recently, the association between blood group
antigens and atherosclerotic heart disease is being investi-
gated. Findings suggest that Group A can be considered as a
risk factor for atherosclerotic heart disease [7,8]. A similar
association could not be demonstrated in our study.4.1. Study limitations
First, our data is applicable only to the patients suffering from
severe rheumatic valve involvement, thus we cannot general-
ize our study results to patients with mild to moderate
involvement. Second, this is a retrospectively study. Thus,
potential unavoidable confounding factors related to the
retrospective studies should be kept in mind.
In summary, there was no association between rheumatic
valve disease and blood group antigens in people living in the
Southeastern Anatolian endemic region. Blood group does
not seem to be a risk factor for severe rheumatic valve
involvement or the severity of the disease.r e f e r e n c e s
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